Zachary Patrick Fricker, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
End Stage Liver Disease | 9 | 2024 | 352 | 2.400 |
Why?
|
Liver Cirrhosis | 11 | 2024 | 1932 | 1.590 |
Why?
|
Liver Transplantation | 6 | 2024 | 2332 | 0.820 |
Why?
|
Cholangitis, Sclerosing | 1 | 2019 | 176 | 0.550 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2024 | 991 | 0.520 |
Why?
|
Health Plan Implementation | 1 | 2019 | 336 | 0.520 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2018 | 1128 | 0.480 |
Why?
|
Hepatitis B, Chronic | 1 | 2019 | 410 | 0.480 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 612 | 0.440 |
Why?
|
Waiting Lists | 3 | 2024 | 766 | 0.430 |
Why?
|
Biliary Tract | 1 | 2013 | 135 | 0.390 |
Why?
|
Communicable Diseases | 1 | 2020 | 873 | 0.380 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3821 | 0.370 |
Why?
|
Cost of Illness | 1 | 2019 | 1936 | 0.320 |
Why?
|
Oxidative Stress | 1 | 2018 | 3114 | 0.290 |
Why?
|
Length of Stay | 1 | 2020 | 6417 | 0.260 |
Why?
|
Antiviral Agents | 4 | 2019 | 3048 | 0.260 |
Why?
|
Lypressin | 1 | 2024 | 26 | 0.230 |
Why?
|
Pressure | 1 | 2007 | 1155 | 0.230 |
Why?
|
Palliative Care | 1 | 2019 | 3599 | 0.220 |
Why?
|
Internship and Residency | 1 | 2024 | 5885 | 0.220 |
Why?
|
Hepatorenal Syndrome | 1 | 2024 | 75 | 0.220 |
Why?
|
Hospital Mortality | 3 | 2024 | 5295 | 0.210 |
Why?
|
Ceftriaxone | 1 | 2024 | 175 | 0.210 |
Why?
|
Hepatitis, Autoimmune | 1 | 2024 | 172 | 0.200 |
Why?
|
Catheterization | 1 | 2007 | 1428 | 0.190 |
Why?
|
Liver | 2 | 2017 | 7512 | 0.190 |
Why?
|
Sodium | 2 | 2024 | 1589 | 0.190 |
Why?
|
Biopsy | 1 | 2013 | 6781 | 0.180 |
Why?
|
Vasoconstrictor Agents | 1 | 2024 | 655 | 0.180 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1027 | 0.170 |
Why?
|
Liver Abscess, Pyogenic | 1 | 2019 | 7 | 0.170 |
Why?
|
Hepatitis, Alcoholic | 1 | 2021 | 109 | 0.170 |
Why?
|
Acute Kidney Injury | 2 | 2024 | 1923 | 0.170 |
Why?
|
Immunocompetence | 1 | 2019 | 138 | 0.160 |
Why?
|
Fusobacterium Infections | 1 | 2019 | 53 | 0.160 |
Why?
|
Severity of Illness Index | 6 | 2024 | 15841 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2023 | 2293 | 0.160 |
Why?
|
Hepatitis B e Antigens | 1 | 2019 | 133 | 0.160 |
Why?
|
Inflammation | 1 | 2018 | 10759 | 0.160 |
Why?
|
Fusobacterium nucleatum | 1 | 2019 | 176 | 0.150 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2019 | 294 | 0.150 |
Why?
|
Hospitals, Urban | 1 | 2020 | 500 | 0.150 |
Why?
|
Disease Progression | 3 | 2019 | 13511 | 0.150 |
Why?
|
Renal Dialysis | 1 | 2007 | 1796 | 0.150 |
Why?
|
Retrospective Studies | 13 | 2024 | 80675 | 0.140 |
Why?
|
Pharmaceutical Services | 1 | 2018 | 141 | 0.140 |
Why?
|
Alanine Transaminase | 1 | 2019 | 602 | 0.130 |
Why?
|
Diabetes Complications | 1 | 2023 | 1316 | 0.130 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4310 | 0.130 |
Why?
|
Models, Statistical | 2 | 2020 | 5081 | 0.120 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2020 | 585 | 0.120 |
Why?
|
Models, Theoretical | 1 | 2007 | 3571 | 0.120 |
Why?
|
Hepacivirus | 2 | 2018 | 1330 | 0.110 |
Why?
|
Humans | 30 | 2024 | 761222 | 0.110 |
Why?
|
Reimbursement Mechanisms | 1 | 2019 | 667 | 0.110 |
Why?
|
Viral Load | 2 | 2019 | 3328 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2024 | 5250 | 0.100 |
Why?
|
Middle Aged | 15 | 2024 | 220858 | 0.100 |
Why?
|
DNA, Viral | 1 | 2019 | 2195 | 0.100 |
Why?
|
Jugular Veins | 1 | 2013 | 210 | 0.100 |
Why?
|
Risk Factors | 6 | 2021 | 74241 | 0.090 |
Why?
|
Female | 18 | 2024 | 392552 | 0.090 |
Why?
|
Male | 19 | 2024 | 360703 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1422 | 0.090 |
Why?
|
Pilot Projects | 1 | 2024 | 8642 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4014 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2014 | 600 | 0.080 |
Why?
|
Cues | 1 | 2014 | 875 | 0.080 |
Why?
|
Parietal Lobe | 1 | 2014 | 852 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1989 | 0.080 |
Why?
|
Aged | 10 | 2024 | 169292 | 0.080 |
Why?
|
Hepatitis C | 1 | 2018 | 1579 | 0.080 |
Why?
|
Flowmeters | 1 | 2007 | 6 | 0.070 |
Why?
|
Pyramidal Tracts | 1 | 2009 | 251 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 1923 | 0.070 |
Why?
|
Transducers, Pressure | 1 | 2007 | 51 | 0.070 |
Why?
|
Veterans | 1 | 2021 | 2656 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12159 | 0.070 |
Why?
|
Prognosis | 4 | 2021 | 29688 | 0.070 |
Why?
|
Functional Laterality | 2 | 2014 | 2257 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4246 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3453 | 0.070 |
Why?
|
Motor Skills | 1 | 2009 | 521 | 0.070 |
Why?
|
Temporal Lobe | 1 | 2014 | 1695 | 0.070 |
Why?
|
Rheology | 1 | 2007 | 347 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 64681 | 0.060 |
Why?
|
Midodrine | 1 | 2024 | 24 | 0.060 |
Why?
|
Adult | 8 | 2024 | 221120 | 0.060 |
Why?
|
Cohort Studies | 3 | 2023 | 41496 | 0.060 |
Why?
|
Attention | 1 | 2014 | 2394 | 0.050 |
Why?
|
Octreotide | 1 | 2024 | 154 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15308 | 0.050 |
Why?
|
Hospitalization | 2 | 2019 | 10707 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14610 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2024 | 6486 | 0.050 |
Why?
|
Nerve Net | 1 | 2014 | 2288 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7400 | 0.050 |
Why?
|
United States | 5 | 2024 | 72341 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6974 | 0.050 |
Why?
|
Norepinephrine | 1 | 2024 | 897 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7407 | 0.050 |
Why?
|
Body Mass Index | 1 | 2018 | 12952 | 0.050 |
Why?
|
Obesity | 1 | 2023 | 12940 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21366 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2021 | 385 | 0.040 |
Why?
|
Policy | 1 | 2023 | 506 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 612 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2024 | 2217 | 0.040 |
Why?
|
Equipment Design | 1 | 2007 | 3510 | 0.040 |
Why?
|
Creatinine | 1 | 2024 | 1897 | 0.040 |
Why?
|
Anisotropy | 2 | 2014 | 1284 | 0.040 |
Why?
|
Fatty Liver | 1 | 2024 | 789 | 0.040 |
Why?
|
Lost to Follow-Up | 1 | 2018 | 123 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13367 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2021 | 482 | 0.030 |
Why?
|
Lipoproteins | 1 | 2021 | 877 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2024 | 1116 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2052 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2024 | 3726 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3843 | 0.030 |
Why?
|
Language Tests | 1 | 2014 | 190 | 0.030 |
Why?
|
Anticipation, Psychological | 1 | 2014 | 84 | 0.030 |
Why?
|
Chronic Disease | 2 | 2024 | 9319 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3584 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15521 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2018 | 706 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2902 | 0.030 |
Why?
|
Orientation | 1 | 2014 | 320 | 0.030 |
Why?
|
Fixation, Ocular | 1 | 2014 | 242 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1935 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 2 | 2014 | 2401 | 0.020 |
Why?
|
Space Perception | 1 | 2014 | 465 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3149 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12474 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 59222 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 7965 | 0.020 |
Why?
|
Organ Size | 1 | 2014 | 2253 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 24022 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2017 | 1702 | 0.020 |
Why?
|
Adolescent | 2 | 2014 | 88300 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2014 | 1984 | 0.020 |
Why?
|
Reaction Time | 1 | 2014 | 2087 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2014 | 1416 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9721 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12052 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12747 | 0.020 |
Why?
|
Brain | 1 | 2014 | 27094 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13249 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1880 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3881 | 0.020 |
Why?
|
Blood Glucose | 1 | 2019 | 6392 | 0.010 |
Why?
|
Patient Readmission | 1 | 2019 | 3265 | 0.010 |
Why?
|
Language | 1 | 2014 | 1539 | 0.010 |
Why?
|
Comorbidity | 1 | 2019 | 10516 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3808 | 0.010 |
Why?
|
Neural Pathways | 1 | 2014 | 3056 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26072 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 39957 | 0.010 |
Why?
|
Transcription Factors | 1 | 2017 | 12101 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 36415 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4052 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54437 | 0.010 |
Why?
|
Brain Mapping | 1 | 2009 | 6635 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42225 | 0.010 |
Why?
|
Child | 1 | 2014 | 80154 | 0.000 |
Why?
|